DexCom ROE 2010-2024 | DXCM
Current and historical return on equity (ROE) values for DexCom (DXCM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| DexCom ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $0.58B | $2.10B | 26.34% |
| 2024-09-30 | $0.68B | $1.98B | 31.21% |
| 2024-06-30 | $0.67B | $2.43B | 29.59% |
| 2024-03-31 | $0.64B | $2.25B | 29.43% |
| 2023-12-31 | $0.54B | $2.07B | 25.01% |
| 2023-09-30 | $0.38B | $2.27B | 17.31% |
| 2023-06-30 | $0.36B | $2.10B | 17.27% |
| 2023-03-31 | $0.29B | $2.23B | 13.88% |
| 2022-12-31 | $0.34B | $2.13B | 16.23% |
| 2022-09-30 | $0.24B | $1.83B | 11.74% |
| 2022-06-30 | $0.23B | $2.26B | 10.67% |
| 2022-03-31 | $0.26B | $2.19B | 12.29% |
| 2021-12-31 | $0.22B | $2.04B | 10.74% |
| 2021-09-30 | $0.63B | $2.14B | 32.20% |
| 2021-06-30 | $0.62B | $2.00B | 34.21% |
| 2021-03-31 | $0.59B | $1.90B | 35.61% |
| 2020-12-31 | $0.55B | $1.83B | 39.11% |
| 2020-09-30 | $0.23B | $1.50B | 19.78% |
| 2020-06-30 | $0.21B | $1.35B | 20.83% |
| 2020-03-31 | $0.15B | $0.94B | 18.10% |
| 2019-12-31 | $0.10B | $0.88B | 13.45% |
| 2019-09-30 | $-0.17B | $0.76B | -24.71% |
| 2019-06-30 | $-0.17B | $0.69B | -26.49% |
| 2019-03-31 | $-0.13B | $0.67B | -21.89% |
| 2018-12-31 | $-0.13B | $0.66B | -23.86% |
| 2018-09-30 | $0.04B | $0.56B | 9.34% |
| 2018-06-30 | $-0.01B | $0.48B | -1.17% |
| 2018-03-31 | $-0.03B | $0.42B | -8.11% |
| 2017-12-31 | $-0.05B | $0.42B | -13.94% |
| 2017-09-30 | $-0.05B | $0.38B | -14.77% |
| 2017-06-30 | $-0.07B | $0.35B | -22.07% |
| 2017-03-31 | $-0.09B | $0.28B | -32.90% |
| 2016-12-31 | $-0.07B | $0.28B | -25.42% |
| 2016-09-30 | $-0.06B | $0.26B | -23.33% |
| 2016-06-30 | $-0.08B | $0.25B | -35.91% |
| 2016-03-31 | $-0.06B | $0.23B | -31.37% |
| 2015-12-31 | $-0.06B | $0.22B | -31.61% |
| 2015-09-30 | $-0.06B | $0.19B | -36.14% |
| 2015-06-30 | $-0.02B | $0.17B | -14.61% |
| 2015-03-31 | $-0.02B | $0.15B | -18.25% |
| 2014-12-31 | $-0.02B | $0.14B | -20.67% |
| 2014-09-30 | $-0.03B | $0.12B | -27.76% |
| 2014-06-30 | $-0.03B | $0.10B | -32.09% |
| 2014-03-31 | $-0.03B | $0.09B | -39.88% |
| 2013-12-31 | $-0.03B | $0.08B | -39.34% |
| 2013-09-30 | $-0.04B | $0.08B | -46.98% |
| 2013-06-30 | $-0.05B | $0.07B | -60.73% |
| 2013-03-31 | $-0.05B | $0.07B | -63.35% |
| 2012-12-31 | $-0.05B | $0.08B | -62.07% |
| 2012-09-30 | $-0.06B | $0.08B | -61.70% |
| 2012-06-30 | $-0.05B | $0.09B | -52.81% |
| 2012-03-31 | $-0.05B | $0.10B | -41.82% |
| 2011-12-31 | $-0.04B | $0.11B | -44.78% |
| 2011-09-30 | $-0.04B | $0.11B | -48.14% |
| 2011-06-30 | $-0.04B | $0.12B | -61.99% |
| 2011-03-31 | $-0.05B | $0.05B | -98.95% |
| 2010-12-31 | $-0.06B | $0.06B | -119.57% |
| 2010-09-30 | $-0.06B | $0.04B | -217.14% |
| 2010-06-30 | $-0.06B | $0.04B | -380.33% |
| 2010-03-31 | $-0.06B | $0.05B | -1109.09% |
| 2009-12-31 | $-0.05B | $-0.02B | 2160.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $33.349B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $201.227B | 88.14 |
| Thermo Fisher Scientific (TMO) | United States | $163.300B | 19.75 |
| Alcon (ALC) | Switzerland | $46.755B | 31.08 |
| Edwards Lifesciences (EW) | United States | $43.878B | 28.77 |
| IDEXX Laboratories (IDXX) | United States | $40.977B | 47.09 |
| IQVIA Holdings (IQV) | United States | $27.010B | 15.13 |
| Mettler-Toledo (MTD) | United States | $24.411B | 29.03 |
| STERIS (STE) | Ireland | $22.902B | 26.19 |
| Waters (WAT) | United States | $21.820B | 30.79 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.782B | 0.00 |
| Hologic (HOLX) | United States | $13.106B | 14.24 |
| Penumbra (PEN) | United States | $11.523B | 90.44 |
| Sysmex ADR (SSMXY) | Japan | $11.349B | 0.00 |
| Masimo (MASI) | United States | $8.868B | 32.71 |
| Globus Medical (GMED) | United States | $8.116B | 19.03 |
| Teleflex (TFX) | United States | $5.711B | 9.43 |
| Glaukos (GKOS) | United States | $5.408B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.211B | 22.07 |
| TransMedics (TMDX) | United States | $4.016B | 87.30 |
| PROCEPT BioRobotics (PRCT) | United States | $3.012B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.466B | 14.69 |
| Veracyte (VCYT) | United States | $2.409B | 33.80 |
| Nihon Kohden (NHNKY) | Japan | $2.072B | 11.33 |
| Elekta AB (EKTAY) | Sweden | $1.983B | 17.83 |
| Alphatec Holdings (ATEC) | United States | $1.852B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.562B | 0.00 |
| Artivion (AORT) | United States | $1.229B | 115.08 |
| Pulse Biosciences (PLSE) | United States | $1.130B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.062B | 5.65 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.800B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.696B | 15.20 |
| IRadimed (IRMD) | United States | $0.668B | 33.92 |
| Beta Bionics (BBNX) | United States | $0.615B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.42 |
| OrthoPediatrics (KIDS) | United States | $0.565B | 0.00 |
| RxSight (RXST) | United States | $0.559B | 0.00 |
| AxoGen (AXGN) | United States | $0.519B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.503B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.485B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.452B | 0.00 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.382B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.334B | 7.10 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.273B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.226B | 13.69 |
| 908 Devices (MASS) | United States | $0.205B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.197B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.163B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.126B | 0.00 |
| CVRx (CVRX) | United States | $0.124B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.116B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.093B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.075B | 11.38 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.25 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.06 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |